Related by context. Frequent words. (Click for all words.) 69 forodesine 68 lispro 67 liposomal formulation 67 nab paclitaxel 65 pramlintide 65 APTIVUS 65 MKC# 64 glargine 64 coadministration 64 sipuleucel T 64 squalamine 63 octreotide 63 QTc prolongation 63 Lantus ® 63 decitabine 63 Pivotal Phase III 63 Dasatinib 62 6R BH4 62 AZOR 62 alpha blocker 62 pharmacodynamic effects 62 administered subcutaneously 62 Natalizumab 62 Lantus R 62 goserelin 62 VIAject 62 INCB# [001] 62 cangrelor 62 antithrombotic 62 elotuzumab 62 dose titration 62 Eltrombopag 62 Monotherapy 61 AVANDIA 61 Phase IIb trials 61 mg QD 61 EVIZON 61 IMC A# 61 warfarin therapy 61 TOLAMBA 61 tumor lysis syndrome 61 Mipomersen 61 hypomagnesemia 61 advanced carcinoid 60 PRADAXA 60 GHRH 60 superficial bladder cancer 60 Phase 2a trial 60 Pioglitazone 60 therapeutic regimens 60 tanespimycin 60 Phase Ib clinical 60 ADHF 60 PEG SN# 60 alagebrium 60 chemoradiotherapy 60 ATL# [001] 60 phase IIb clinical 60 Well Tolerated 60 pharmacokinetic PK 60 fasting plasma glucose 60 Phase III Clinical Trial 60 antihypertensive therapy 60 nitazoxanide 60 Traficet EN 60 PRISTIQ 60 metreleptin 60 mcg kg 60 Bicifadine 60 TYGACIL 60 tirofiban 60 CCX# 60 docetaxel chemotherapy 60 Capecitabine 60 Diamyd ® 60 Laquinimod 60 Secondary endpoints include 60 Panzem R 59 enzastaurin 59 teduglutide 59 pertuzumab 59 peginterferon alfa 2b 59 adalimumab 59 basal insulin 59 MIRCERA 59 Fibrillex TM 59 Phase IIB 59 Pivotal Phase 59 fluvastatin 59 DOXIL 59 mycophenolate mofetil 59 gout flares 59 ZD# [001] 59 Irinotecan 59 undetectable HCV RNA 59 pharmacokinetics PK 59 virologic failure 59 adecatumumab 59 VIAject ® 59 hypocalcemia 59 registrational trial